Nonpublication and Selective Outcome Reporting of Oral Health Trials

被引:2
|
作者
Diakonoff, H. [1 ,2 ]
Khalil, G. [3 ]
Jungo, S. [1 ,4 ]
Treluyer, J. M. [3 ,5 ,6 ]
Fron-Chabouis, H. [7 ,8 ,9 ]
Smail-Faugeron, V. [1 ,3 ,4 ,10 ]
机构
[1] Univ Paris Cite, Fac Sante, UFR Odontol, Paris, France
[2] Univ Paris, Inst Droit & Sante, INSERM, UMR S 1145, Paris, France
[3] Univ Paris, EA7323 Pediat & Perinatal Drug Evaluat & Pharmacol, Paris, France
[4] Bretonneau Hosp, Dent Med Dept, AP HP, Paris, France
[5] Necker Enfants Malad Hosp, Pediat Intens Care Unit, AP HP, Paris, France
[6] Necker Enfants Malad Hosp, AP HP, Clin Res Unit Paris Descartes CIC P1419, Paris, France
[7] Univ Bordeaux 2, Fac Odontol, Bordeaux, France
[8] CNRS, UMR5026, Lab ICMCB, Pessac, France
[9] CHU Bordeaux, Hop St Andre, Serv Med & Chirurg Buccodent, Bordeaux, France
[10] Bretonneau Hosp, AP HP, Dent Med Dept, 1 Rue Maurice Arnoux, F-75184 Paris, France
关键词
clinical protocols; randomized controlled trial; publication bias; humans; registries; bias; RANDOMIZED-TRIALS; INCREASING VALUE; CLINICAL-TRIALS; PROTOCOLS; CLINICALTRIALS.GOV; PUBLICATIONS; REGISTRATION; REGISTRIES;
D O I
10.1177/00220345231158544
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Less than one-quarter of oral health trials are registered in a public registry. However, no study has assessed the extent of study publication and selective outcome reporting bias in the field of oral health. We identified oral health trials registered between 2006 and 2016 in ClinicalTrials.gov. We assessed whether results of early discontinued trials, trials having an unknown status, and completed trials had been published and, among published trials, whether outcomes differed between the registered record and the corresponding publication. We included 1,399 trials, of which 81 (5.8%) were discontinued, 247 (17.7%) had an unknown status, and 1,071 (76.6%) were completed. The registration was prospective for 719 (51.9%) trials. Over half the registered trials were unpublished (n = 793, 56.7%). To explore the association between trials publication and characteristics of trials, we performed a multivariate logistic regression analysis. Trials conducted in the United States (P = 0.003) or Brazil (P < 0.001) were associated with increased odds of publication, whereas trials registered prospectively (P = 0.001) and industry-sponsored trials (P = 0.02) were associated with decreased odds. Among the 479 published trials with completed status, the primary outcomes of 215 (44.9%) articles differed from that registered. Major discrepancies consisted of the introduction of a new primary outcome in the published article (196 [91.2%]) and the transformation of a registered secondary outcome into a primary outcome (112 [52.1%]). In the remaining 264 (55.1%) trials, primary outcomes did not differ from that registered, but 141 (53.4%) had been registered retrospectively. Our study highlights the high rate of nonpublication and selective outcome reporting in the field of oral health. These results could alert sponsors, funders, authors of systematic reviews, and the oral health research community at large to combat the nondisclosure of trial results.
引用
收藏
页码:599 / 607
页数:9
相关论文
共 50 条
  • [41] Nonpublication and discontinuation of randomised controlled trials in newborns
    Ruegger, Christoph M.
    Dawson, Jennifer A.
    Donath, Susan M.
    Owen, Louise S.
    Davis, Peter G.
    ACTA PAEDIATRICA, 2017, 106 (12) : 1940 - 1944
  • [42] Inconsistent Outcome Reporting in Heart Failure Randomized Controlled Trials
    Siddiqi, Tariq Jamal
    Shahid, Izza
    Arshad, Muhammad Sameer
    Greene, Stephen J.
    Pandey, Ambarish
    Vaduganathan, Muthiah
    Spall, Harriette G. c. Van
    Mentz, Robert J.
    Khan, Shahzeb
    JOURNAL OF CARDIAC FAILURE, 2023, 29 (04) : 425 - 433
  • [43] Analysis of the discontinuation and nonpublication of neurooncological randomized clinical trials
    Butler, Molly
    Mehra, Mehul
    Chandasir, Abdullah
    Kaoutzani, Lydia
    Vale, Fernando L.
    NEURO-ONCOLOGY ADVANCES, 2024, 6 (01)
  • [44] Outcome Reporting in Industry-Sponsored Trials of Gabapentin for Off-Label Use.
    Vedula, S. Swaroop
    Bero, Lisa
    Scherer, Roberta W.
    Dickersin, Kay
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (20) : 1963 - 1971
  • [45] Discontinuation and Nonpublication of Randomized Clinical Trials Conducted in Children
    Pica, Natalie
    Bourgeois, Florence
    PEDIATRICS, 2016, 138 (03)
  • [46] Trials of antenatal corticosteroids for preterm fetal lung maturity: a review of the potential for selective outcome reporting
    White, Victoria A.
    Walker, Kate F.
    Thornton, Jim G.
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2019, 236 : 58 - 68
  • [47] Bias in reporting clinical trials
    Bardy, AH
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 46 (02) : 147 - 150
  • [48] Selective outcome reporting concerning antibiotics and third molar surgery
    Fagoni, Thalita Guarda
    Rafalovich, Vanessa Cristina
    Brozoski, Mariana Aparecida
    Deboni, Maria Cristina Zindel
    de Oliveira, Natacha Kalline
    CLINICAL ORAL INVESTIGATIONS, 2025, 29 (01)
  • [49] Frequency and reasons for outcome reporting bias in clinical trials: interviews with trialists
    Smyth, R. M. D.
    Kirkham, J. J.
    Jacoby, A.
    Altman, D. G.
    Gamble, C.
    Williamson, P. R.
    BMJ-BRITISH MEDICAL JOURNAL, 2011, 342 : 155
  • [50] Quality and consistency of outcome reporting in clinical trials of immunosuppression in renal transplantation
    Hussain, Samia
    Knight, Simon R.
    CLINICAL TRANSPLANTATION, 2016, 30 (11) : 1440 - 1448